GH Research PLC
NASDAQ:GHRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GH Research PLC
NASDAQ:GHRS
|
IE |
|
D
|
Dgb Asia Bhd
KLSE:DGB
|
MY |
|
H
|
HELLENiQ ENERGY Holdings SA
F:HLPN
|
GR |
|
E
|
Eni SpA
DUS:ENI
|
IT |
|
T
|
Taewoong Co Ltd
KOSDAQ:044490
|
KR |
|
L
|
Lucid Diagnostics Inc
NASDAQ:LUCD
|
US |
|
L
|
Lattice Semiconductor Corp
F:LTT
|
US |
|
X
|
XCure Corp
KOSDAQ:070300
|
KR |
|
E
|
Equites Property Fund Ltd
JSE:EQU
|
ZA |
|
G
|
GH Research PLC
SWB:1KA
|
IE |
Intrinsic Value
Is GHRS undervalued or overvalued?
See the intrinsic value estimate for GH Research PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What GH Research Does
GH Research PLC is a clinical-stage biopharmaceutical company focused on mental health. It is developing inhaled drug candidates, led by GH001, for severe psychiatric conditions such as treatment-resistant depression. The company is not a drug seller today; its work is to run clinical studies, build the evidence needed for regulators, and move its compounds toward approval.
- Headquarters
- Ireland IE
- Employees
- 73
- IPO date
- Jun 25, 2021
Earnings Waterfall
GH Research PLC
The intrinsic value for GH Research PLC (GHRS) under the Base Case is hidden USD.
Compared with the current market price of 18.44 USD, the stock appears hidden.